Vol 2014, No 4 (2014)

Table of Contents

Research & Development

BMS Expands Immuno-Oncology Pipeline with Five Prime Partnership Abstract
Heather Cartwright
Celgene Gains Option to Buy Partner Forma Therapeutics via US$600 M Multistage Collaboration Abstract
Heather Cartwright

Mergers & Acquisitions

Horizon Pharma Looks to Tax Efficiency with Acquisition of Ireland’s Vidara Therapeutics Abstract
Heather Cartwright
Baxter Follows Abbott’s Lead with Plan to Split into Two Independent Companies Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.